Loading...
MTAA
REC
Market cap11bUSD
Dec 04, Last price  
48.88EUR
1D
-1.17%
1Q
-9.57%
Jan 2017
81.58%
Name

Recordati Industria Chimica e Farmaceutica SpA

Chart & Performance

D1W1MN
MTAA:REC chart
P/E
24.10
P/S
4.29
EPS
2.03
Div Yield, %
1.29%
Shrs. gr., 5y
Rev. gr., 5y
9.58%
Revenues
2.34b
+12.45%
576,080,000576,186,000628,435,000689,634,000747,524,000728,134,000762,036,000828,317,000941,630,000987,356,0001,047,676,0001,153,942,0001,288,123,0001,352,235,0001,481,848,0001,448,867,0001,580,074,0001,853,307,0002,082,331,0002,341,559,000
Net income
417m
+7.01%
64,543,00074,031,00084,865,000100,429,000110,566,000108,580,000116,446,000118,484,000133,678,000161,187,000198,792,000237,406,000288,762,000312,376,000368,825,000354,984,000385,966,000312,336,000389,214,000416,508,000
CFO
570m
+17.43%
83,061,00096,594,00091,820,000147,616,000155,019,000140,575,000121,460,000112,752,000170,119,000179,155,000247,372,000255,436,000272,711,000371,577,000334,027,000403,575,000491,650,000461,691,000485,319,000569,918,000
Dividend
May 20, 20240.63 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.
IPO date
Jan 01, 1984
Employees
4,300
Domiciled in
IT
Incorporated in
IT

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT